Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Keytruda
Keytruda
In PD-1 rivalry, Merck's Keytruda catches up with Opdivo in rare lung cancer type
Fierce Pharma
Fri, 03/10/23 - 11:20 am
Merck
Keytruda
Opdivo
Bristol Myers Squibb
pleural mseothelioma
mesothelioma
clinical trials
Merck reports two Phase 3 study misses for Keytruda
BioPharma Dive
Tue, 02/28/23 - 10:43 pm
Merck
clinical trials
Keytruda
prostate cancer
lung cancer
Keytruda killer: Chipscreen bags Chinese rights to Biocytogen's bispecific antibody
Fierce Biotech
Tue, 02/28/23 - 09:56 am
cancer
Biocytogen
Chipscreen NewWay Biosciences
Merck
Keytruda
YH008
Warren urges US patent office to scrutinize Merck's efforts with Keytruda
Fierce Pharma
Thu, 02/23/23 - 04:25 pm
Merck
Keytruda
Senate
Elizabeth Warren
patents
Big pharma’s looming threat: a patent cliff of ‘tectonic magnitude’
BioPharma Dive
Tue, 02/21/23 - 11:05 am
Big Pharma
patents
patent cliff
biosimilars
AbbVie
Humira
Merck
Keytruda
Bristol Myers Squibb
Opdivo
Merck targets BMS' stomach cancer head start with Keytruda win, but past failure casts shadow
Fierce Pharma
Thu, 02/16/23 - 04:54 pm
Merck
Keytruda
clinical trials
stomach cancer
After several flops, Merck exec stands by aggressive Keytruda prostate cancer program
Fierce Biotech
Thu, 02/16/23 - 11:06 am
Merck
Keytruda
prostate cancer
The end of the Humira era
EP Vantage
Mon, 01/30/23 - 10:46 am
AbbVie
Humira
patents
biosimilars
Merck
Keytruda
A Hit and a Miss for Merck’s Keytruda
BioSpace
Wed, 01/25/23 - 10:42 am
Merck
Keytruda
prostate cancer
biliary tract cancer
Immuno-oncology goes subcutaneous
EP Vantage
Wed, 01/25/23 - 10:18 am
immuno-oncology
oncology
subcutaneous drug delivery
Keytruda
Merck
Tecentriq
Roche
Chasing Roche, Merck talks up subcutaneous Keytruda ahead of phase 3 data drop
Fierce Pharma
Mon, 01/16/23 - 11:16 am
Merck
Keytruda
Roche
cancer
oncology
BioXcel, keeping cards close to its chest, teases phase 2 Keytruda combination trial data drop
Fierce Biotech
Wed, 01/11/23 - 11:00 am
BioXcel Therapeutics
clinical trials
Keytruda
BXCL701
prostate cancer
Merck Highlights Growth Strategy at J.P. Morgan
BioSpace
Tue, 01/10/23 - 06:48 pm
Merck
JPMHC 2023
Keytruda
vaccines
M&A
OncoC4 doses first participant in ovarian cancer therapy trial
Clinical Trials Arena
Mon, 01/2/23 - 06:33 pm
OncoC4
clinical trials
ONC-392
Merck
Keytruda
ovarian cancer
platinum-resistant ovarian cancer
Moderna, Merck & Co. mRNA cancer vaccine slashes melanoma recurrence in Keytruda combo trial
Fierce Biotech
Tue, 12/13/22 - 10:35 am
Merck
Moderna Therapeutics
MRNA
cancer immunotherapy
Keytruda
melanoma
Mirati to focus adagrasib/Keytruda study in low PDL1 lung cancer patients
Yahoo/Reuters
Tue, 12/6/22 - 10:21 am
Mirati Therapeutics
adagrasib
Merck
Keytruda
metastatic lung cancer
lung cancer
GSK unveils Keytruda head-to-head data in lung cancer—and they look good at first glance
Fierce Pharma
Wed, 11/30/22 - 07:58 pm
GSK
Merck
Jemperli
Keytruda
clinical trials
non-small cell lung cancer
Merck scores another win for Keytruda, this time in HER2-negative cancer
Endpoints
Tue, 11/22/22 - 04:39 pm
Merck
Keytruda
clinical trials
adenocarcinoma
Is Merck Too Dependent on Keytruda?
Motley Fool
Wed, 11/9/22 - 10:50 am
Merck
Keytruda
Catching up with Keytruda, Regeneron scores frontline NSCLC approval for Libtayo/chemo combo
Endpoints
Wed, 11/9/22 - 10:38 am
Regeneron
Libtayo
non-small cell lung cancer
Keytruda
Merck
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »